RA-Map Early Rheumatoid Arthritis patient genotyping (InfiniumCoreExome-24-v1)

• GRU-CC DUO:0000005 (version: 2019-01-07)general research use and clinical careThis data use limitation indicates that use is allowed for health/medical/biomedical purposes and other biological research, including the study of population origins or ancestry.
• RU DUO:0000014 (version: 2019-01-07)research use onlyThis data use limitation indicates that use is limited to research purposes (e.g., does not include its use in clinical care).
• PUB DUO:0000019 (version: 2019-01-07)publication requiredThis data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.
• IS DUO:0000028 (version: 2019-01-07)institution specific restrictionThis data use modifier indicates that use is limited to use within an approved institution.

Data provided is on condition of full attribution of the RA-Map consortium in acknowledgment, in adherence to the RA-MAP Consortium’s publication policy. Data should not be passed to third parties, all results relating to RA-Map subjects should be shared with the RA-MAP consortium.

Data provided is on condition of full attribution of the RA-Map consortium in acknowledgment, in adherence to the RA-MAP Consortium’s publication policy. Data should not be passed to third parties, all results relating to RA-Map subjects should be shared with the RA-MAP consortium. RA-MAP Consortium’s publication policy All publications relating to this data should include the following acknowledgement "genotype data was funded by the MRC/ABPI Inflammation and Immunology Initiative Grant (MRC reference numbers: G1001516 and G1001518).